Q1 2022

Filed May 9, 2022 · 10-Q · 39 days after period end · 0000877860-22-000041

Q1 2022 · 10-Q

Revenue

$0.00

−100.0% vs Q1 2021

Net Income

$8.40M

−76.2% vs Q1 2021

EPS Diluted

$0.18

−76.9% vs Q1 2021

Operating Cash Flow$38,680,000−32.0%

Same quarter

Metric	Q1 2022	Q1 2021	Q1 2020	Q1 2019
Revenue	$0.00	$80.89M	$83.08M	$76.11M
Net Income	$8.40M	$35.33M	$61.02M	$35.68M
EPS Diluted	$0.18	$0.78	$1.37	$0.83

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR